Summary:
We are currently seeking patients for the TRIAD Research Study. The study is evaluating the effectiveness, safety, and tolerability of an investigational medication that may reduce symptoms of agitation due to Alzheimer’s disease.
Agitation due to Alzheimer’s disease can make caring for your loved one challenging and stressful.
Qualified Participants Must:
• Have moderate to severe agitation due to Alzheimer’s disease
•
Be between 50 and 90 years of age
•
Have a caregiver who is able to attend all study visits
Qualified Participants May Receive:
Additionally, certain qualified patients may have the opportunity to receive the investigational medication for an additional year, as part of an extension study.
Qualified participants will receive study-related tests and procedures at no cost. In addition to evaluations, each study visit will also provide an opportunity for the participant and caregiver to meet with the study team, address any questions they may have, and share their experiences. Participants and/or caregivers may be compensated for their time and travel.